Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79362493392629399a529d819cdccd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2697de8d254f6515604d2cf59730970 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
filingDate |
2015-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
PT-3185867-T |
titleOfInvention |
CRYSTALLIZATION PROCESS OF ARIPIPRAZOL DERIVATIVES IN PROLONGED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA |
priorityDate |
2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |